Cadrenal Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Cadrenal Therapeutics, Inc. reported Common Stock Shares Outstanding of 2.34 million shares for the year ending 2025.

  • Cadrenal Therapeutics, Inc. showed an increase of +31.2% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Cadrenal Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Cadrenal Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 71.5%.
  • Historical annual values: Fiscal year 2025: 2.34 million shares | Fiscal year 2024: 1.78 million shares | Fiscal year 2023: 868,184 shares | Fiscal year 2022: 8.19 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: